Pan-cancer analysis verifies COLGALT1 as a potential target for immunotherapy and survival prognosis

被引：0
|
作者：
Wang, Fengyan [1 ]
机构：
[1] Shandong First Med Univ & Shandong Prov Qianfosha, Affiliated Hosp 1, Jinan, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
COLGALT1; immune cell infiltration; immunotherapy; pancancer; tumor immune microenvironment;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
No.0161
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [21] Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
    Tang, Yumei
    Lei, Ye
    Gao, Peng
    Jia, Junting
    Du, Huijun
    Wang, Qitong
    Yan, Zhixin
    Zhang, Chen
    Liang, Guojun
    Wang, Yanfeng
    Ma, Weijun
    Xing, Nianzeng
    Cheng, Le
    Ren, Laifeng
    BMC CANCER, 2023, 23 (01)
  • [22] A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
    Zhuang, Lingling
    Sun, Qiran
    Huang, Shenglan
    Hu, Lanyan
    Chen, Qi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [23] Comprehensive pan-cancer analysis of LAMAS: implications for prognosis and immunotherapy
    Huang, Hui
    Dong, Wei
    Qin, Xuan
    Usama, Ali
    Cheema, Anees
    Deng, Chunlei
    Sarfaraz, Sara
    Pan, Qingyun
    Alhomrani, Majid
    Alamri, Abdulhakeem S.
    Alsuhaymi, Naif
    Alghamdi, Saleh A.
    Alghamdi, Ahmad A.
    Zheng, Su
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2025, 17 (02):
  • [24] Potential prognosis and immunotherapy predictor TFAP2A in pan-cancer
    Niu, Chenxi
    Wen, Haixuan
    Wang, Shutong
    Shu, Guang
    Wang, Maonan
    Yi, Hanxi
    Guo, Ke
    Pan, Qiong
    Yin, Gang
    AGING-US, 2024, 16 (02): : 1021 - 1048
  • [25] A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
    Lingling Zhuang
    Qiran Sun
    Shenglan Huang
    Lanyan Hu
    Qi Chen
    Scientific Reports, 13
  • [26] Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy
    Chen, Yu
    He, Jialin
    Chen, Rui
    Wang, Zeyu
    Dai, Ziyu
    Liang, Xisong
    Wu, Wantao
    Luo, Peng
    Zhang, Jian
    Peng, Yun
    Zhang, Nan
    Liu, Zaoqu
    Zhang, Liyang
    Zhang, Hao
    Cheng, Quan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] Pan-cancer analysis and KNSTRN as a potential prognosis biomarker
    Xiao, Shanshan
    Zou, Yuqing
    Wang, Li
    Wang, Qian
    Wang, Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types
    Xu, Peiyi
    Zhang, Qiuyan
    Zhai, Jing
    Chen, Pu
    Deng, Xueting
    Miao, Lin
    Zhang, Xiuhua
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [29] NEK2 is a potential pan-cancer biomarker and immunotherapy target
    Zhang, Lanyue
    Li, Yang
    Deng, Juexiao
    Liao, Wenxin
    Liu, Tingting
    Shen, Fujin
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [30] Pan-cancer analysis and single-cell analysis identifies the CENPN as a biomarker for survival prognosis and immunotherapy
    Zhang, Nie
    He, Zhuoying
    Qin, Xuejin
    Han, Ke
    Zhu, Zhengchun
    Zhong, Fei
    DISCOVER ONCOLOGY, 2025, 16 (01)
12345